摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[125I]iodonitrobenzene | 133622-64-7

中文名称
——
中文别名
——
英文名称
4-[125I]iodonitrobenzene
英文别名
1-125Jod-4-nitrobenzol;1-[125I]iodo-4-nitro-benzene;1-(125I)iodanyl-4-nitrobenzene
4-[<sup>125</sup>I]iodonitrobenzene化学式
CAS
133622-64-7
化学式
C6H4INO2
mdl
——
分子量
247.103
InChiKey
SCCCFNJTCDSLCY-SPNOHOMGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    45.8
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    4-硝基苯胺对甲苯磺酸 、 sodium iodide 作用下, 以 乙腈 为溶剂, 反应 2.25h, 以93%的产率得到4-[125I]iodonitrobenzene
    参考文献:
    名称:
    通过稳定的重氮盐对芳基胺进行一锅放射性碘化:制备125 I成像剂
    摘要:
    描述了一种操作简单,一锅,两步的串联程序,该程序允许将放射性碘通过稳定的重氮盐掺入芳基胺中。温和的条件可以耐受各种官能团和取代模式,从而可以后期快速地获得各种125 I标记的芳基化合物和SPECT放射性示踪剂。
    DOI:
    10.1039/c7cc06211g
点击查看最新优质反应信息

文献信息

  • Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts
    作者:François Guérard、Yong-Sok Lee、Kwamena Baidoo、Jean-François Gestin、Martin W. Brechbiel
    DOI:10.1002/chem.201600922
    日期:2016.8.22
    Aryliodonium salts have become precursors of choice for the synthesis of 18F‐labeled tracers for nuclear imaging. However, little is known on the reactivity of these compounds with heavy halides, that is, radioiodide and astatide, at the radiotracer scale. In the first comparative study of radiohalogenation of aryliodonium salts with 125I− and 211At−, initial experiments on a model compound highlight
    盏花盐已成为合成18 F标记的核成像示踪剂的首选前体。然而,在放射性示踪剂规模上,这些化合物与重卤化物,即放射性化物和a化物的反应性知之甚少。与芳基鎓盐的放射性卤化的第一比较研究125我-和211在- ,上模型化合物最初的实验中突出的较高的反应性相比,化物,这不能从先前的卤素系列内观察到的趋势预料到的。动力学研究表明,活化能存在显着差异(E a = 23.5和17.1 kcal mol -1与125我-和211在- ,分别)。量子化学计算表明,stat化作用是通过鎓络合物的单体形式发生的,而化作用是通过异二聚鎓中间体发生的。用不同取代的芳基鎓盐实现的卤代区域选择性良好且产率高,这表明这类化合物是目前用于核医学示踪剂重放射性卤素标记的化学的有前途的替代品。
  • Nickel-Mediated Radioiodination of Aryl and Heteroaryl Bromides: Rapid Synthesis of Tracers for SPECT Imaging
    作者:Alastair A. Cant、Sue Champion、Rajiv Bhalla、Sally L. Pimlott、Andrew Sutherland
    DOI:10.1002/anie.201302800
    日期:2013.7.22
    Rapid and efficient radioiodination of aryl and heteroaryl bromides has been achieved using a nickel(0)‐mediated halogen‐exchange reaction. This transformation gives direct access to [123I]‐ and [125I]‐imaging agents for single photon emission computed tomography (SPECT), such as 5‐[123I]‐A85380 (see scheme, Boc=tert‐butyloxycarbonyl, cod=1,5‐cyclooctadiene, TFA=trifluoroacetic acid).
    使用(0)介导的卤素交换反应已实现了芳基和杂芳基化物的快速有效化。此转换可直接访问用于单光子发射计算机断层扫描(SPECT)的[ 123 I]-和[ 125 I]-成像剂,例如5- [ 123 I] -A85380(请参阅方案,Boc =叔丁氧羰基,化学需氧量= 1,5-环辛二烯,TFA =三氟乙酸)。
  • Rapid Cu-Catalyzed [<sup>211</sup>At]Astatination and [<sup>125</sup>I]Iodination of Boronic Esters at Room Temperature
    作者:Sean W. Reilly、Mehran Makvandi、Kuiying Xu、Robert H. Mach
    DOI:10.1021/acs.orglett.8b00232
    日期:2018.4.6
    Access to At-211- and I-125-radiolabeled compounds in excellent RCCs and RCYs was achieved in just 10 min at room temperature using a Cu catalyst. The reaction conditions are applicable to a broad class of aryl and heteroaryl boronic reagents with varying steric and electronic properties as well as late-stage astatination and iodination of anticancer PARP inhibitors. This protocol eliminates the traditional need for toxic organotin reagents, elevated temperatures, and extended reaction times, providing a more practical and environmentally friendly approach to developing a-emitting radiotherapeutics.
  • Komori, H.; Nishioka, K., Journal of labelled compounds and radiopharmaceuticals, 2001, vol. 44, p. S945 - S947
    作者:Komori, H.、Nishioka, K.
    DOI:——
    日期:——
  • [EN] METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS<br/>[FR] PROCÉDÉ DE SYNTHÈSE DE COMPOSÉS IODO- OU ASTATOARYLE À L'AIDE DE SELS D'ARYLSULFONIUM
    申请人:[en]INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
    公开号:WO2023222909A1
    公开(公告)日:2023-11-23
    The inventors have now succeeded in developing arylsulfonium salts, in particular triarylsulfonium salts and dibenzothiophenium salts and a new use of said arylsulfonium salts. These compounds have the advantage of having a thioaryl group as leaving group, which allows all side products to be separated from the radiolabelled product. Said compounds are therefore useful tools in a method for synthesizing iodo- or astatoarryl compounds, in particular radioiodo- or radioastatoaryl compounds. The present invention relates to a method for synthesizing iodo- or astatoaryl compounds comprising the reaction of an arylsulfonium compound with an iodide or astatide salt, respectively. The invention also relates to arylsulfonium compounds as such. The invention also concerns a method of synthesizing an iodo- or astatolabelled biomolecule and/or vector using said iodo- or astatoraryl compound.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫